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Abstract 
Objective: Herein, we evaluated the efficacy and safety of intra-arterial mild hypothermia in combination with arte-
rial thrombolysis to treat acute cerebral infarction due to middle cerebral artery occlusion.
Methods: A total of 26 patients with acute middle cerebral artery occlusion were divided into a normothermia group 
(n = 15) and a mild hypothermia group (n = 11). The infarct volumes at 24 h and 7 days after the operation were 
compared between the normothermia group and the mild hypothermia group. Additionally, we compared neuro-
logical deficit scores between the two groups at 24 h, 7 days, and 1 mo after the operation.
Results: The infarct volumes and neurological deficit scores of the mild hypothermia group were significantly 
reduced compared to those in the normothermia group (p < 0.05). Furthermore, no adverse reactions or complica-
tions occurred in the mild hypothermia group.
Conclusion: Intra-arterial mild hypothermia reduced infarct volume after ischemia–reperfusion injury in the arterial 
thrombolysis of an acute cerebral infarction. Additionally, it improved the prognosis of patients with an acute middle 
cerebral artery occlusion, suggesting that this procedure is safe and effective for treating acute cerebral infarction.
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Background
Ischemic cerebrovascular disease, which is otherwise 
known as a stroke, is the second leading global cause of 
mortality after coronary heart disease and a major cause 
of neurological disability (Lopez et  al. 2006). Approxi-
mately 17 million strokes occur worldwide each year (Fei-
gin et al. 2014), and stroke is not only a life-threatening 
disease, but also a recurrent disease (Birns and Bhalla 
2015). Following the acute phase, stroke patients often 
require long-term rehabilitation and nursing home care 
with ongoing support from their community (Mikulik 
and Wahlgren 2015). Thus, stroke is a devastating dis-
ease and a major economic burden on society (Mounica 
2015). Moreover, the quality of life of stroke patients gen-
erally remains poor (van Eeden et al. 2015).
Ischemic cerebrovascular disease that involves an acute 
middle cerebral artery occlusion is associated with higher 
rates of disability and mortality (Gawlitza et  al. 2016). 
Typically, for such a condition, early stage intravenous 
thrombolysis is performed (The National Institute of 
Neurological Disorders and Stroke rt-PA Stroke Study 
Group 1995) and the drug alteplase, a tissue plasminogen 
activator, is administered (Campbell et al. 2015a). This is 
the only therapy with a proven efficacy for acute ischemic 
stroke when used within 3–5 h after stroke onset (Fisher 
and Saver 2015). However, because of the complex-
ity of intravenous thrombolysis (Shao et  al. 2015), little 
improvement has been made in the use of thrombolysis 
procedures for acute stroke (Marshall 2015).
The multicenter randomized clinical trial of endovascu-
lar treatment for acute ischemic stroke in the Netherlands 
(MR CLEAN) reported on the efficacy of intra-arterial 
(IA) treatment for acute ischemic stroke (AIS) (Roze-
man et  al. 2016). Their results indicated that IA therapy 
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is beneficial for patients with an acute middle cerebral 
artery occlusion. Arterial thrombolysis can promptly 
restore blood supply to ischemic brain tissue and protect 
the brain tissue within the penumbra. However, arterial 
thrombolysis can also trigger ischemic-reperfusion injury; 
therefore, intra-arterial thrombolysis must be carried out 
within a strict time frame. Ischemia–reperfusion injury is 
a major cause of post-stroke impairment, which seriously 
affects the quality of life and the functional rehabilitation 
of stroke patients (Liu et al. 2015).
Induced hypothermia has been used to prevent or 
reduce ischemia–reperfusion injury. For example, it has 
been shown that a combination of mild hypothermia and 
sodium hydrosulfide treatment is beneficial for reduc-
ing hippocampal apoptosis and pathology (Dai et  al. 
2016). In another study, deep hypothermia and diazox-
ide, a potassium channel activator, were correlated with 
a reduction in DNA fragmentation and the inhibition of 
mitochondrial cytochrome c release and caspase-3 acti-
vation (He et  al. 2008). Further, there have been 5 ran-
domized controlled trials (RCTs) showing the benefit of 
intra-arterial endovascular treatment for acute ischemic 
stroke (MR CLEAN, REVASCAT, ESCAPE, SWIFT 
PRIME, EXTEND-IA) (Berkhemer et  al. 2015; Camp-
bell et al. 2015b; Goyal et al. 2015; Jovin et al. 2015; Saver 
et al. 2015).
Most stroke patients are referred to specialists too late 
for optimal arterial thrombolysis. Thus, we here evalu-
ated the utility of intra-arterial mild hypothermia com-




We selected patients based on five criteria. First, patients 
clinically diagnosed with an acute middle cerebral 
artery occlusion and disease onset of less than 6 h were 
included. Second, patients with early signs of cerebral 
hemorrhage and cerebral infarction shown on a cranial 
computed tomography (CT) scan were excluded. Third, 
we restricted the age of the patients to between 18 and 
75  years, inclusive. Fourth, only patients without severe 
organ dysfunction or a bleeding tendency were included. 
Finally, we required that the etiology of the cerebral 
infarct of the patients was atherosclerosis. Patients with 
a disease onset duration of more than 6 h were excluded 
from surgery of the vascular occlusion. This study was 
conducted in accordance with the declaration of Hel-
sinki. This study was conducted with approval from the 
Ethics Committee of Huazhong University of Science 
and Technology. Written informed consent was obtained 
from all participants. The protocol number of the study 
was QJX2010-43.
Grouping
A total of 26 patients with an acute middle cerebral artery 
occlusion were randomly divided into a normothermia 
group (n = 15) and a mild hypothermia group (n = 11). 
All 26 patients with acute MCA (16 males, 10 females). 
Patients in the mild hypothermia group received arterial 
thrombolysis combined with intra-arterial mild hypo-
thermia. To induce neuroprotection, we used a partial 
mild hypothermia temperature range of 28–33  °C. The 
patients in the conventional treatment group had met 
the inclusion criteria but were either unsuitable for inter-
ventional therapy, or their legal guardian rejected the 
therapy.
Operation
The vascular occlusion site in each patient was confirmed 
using conventional cerebral angiography under anes-
thesia. Using a digital subtraction angiography system, 
we inserted the microguidewire (PT Graphix™, Boston 
Scientific, Marlborough, MA, USA) with a microcath-
eter (Rebar™-18, ev3, Plymouth, MN, USA) through the 
thrombus. Then, the microguidewire was pulled out and 
the angiography was performed through the inserted 
microcatheter. After confirmation that the distal vas-
cular was removed, Ringer’s solution (50  mL/min, total 
500 mL) at 4 °C was pumped into the brain tissue through 
the microcatheter over 10 min so that the temperature of 
the local brain tissue was quickly reduced to induce mild 
hypothermia. The Ringer’s solution consisted of 120 mM 
NaCl, 25 mM NaHCO3, 3.3 mM KCl, 1.2 mM NaH2PO4, 
1.8 mM CaCl2, 2.4 mM MgSO4, and 10 mM dextrose, and 
was percolated with 95% O2 and 5% CO2 before use. Sub-
sequently, super-selective thrombolysis with urokinase 
was carried out through the inserted microcatheter in 
combination with balloon dilatation (Maverike2™, Bos-
ton Scientific), stent embolectomy (Solitaire™ FR, ev3), 
or implantation of the stent into a blood vessel to restore 
blood flow.
Neurological deficit scoring
Neurological deficit scoring according to the National 
Institutes of Health Stroke Scale scoring method was per-
formed at 24 h, 7 days, and 1 mo after the operation.
Determination of infarct volume
The infarct sizes of each patient were determined at 
24 h and 7 days after the operation using cranial mag-
netic resonance imaging (MRI) (Philips, Eindhoven, 
Netherlands) and diffusion weighted imaging. A 3.0 
Tesla MRI scan was performed using a susceptibility 
weighted protocol that was optimized for brain imag-
ing. The infarct volumes were calculated using the 
Streiner formula.
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Determination of clinical indexes
The blood pressure, heart rate, blood glucose, blood gas, 
and coagulation condition of each patient were recorded 
24 h after the operation.
Statistical analysis
SPSS statistical software (version 11.5; IBM Corporation, 
Armonk, NY, USA) was used to analyze the data. Meas-
urement data are reported here as the mean ± standard 
deviation (SD) and groups were compared using a t test. 
Numeration data were compared using a Chi squared 
test. For all of the results, p values less than 0.05 were 
considered statistically significant.
Results
Infarct volumes after induced intra‑arterial mild 
hypothermia
The representative MRIs were presented in the normo-
thermia group and mild hypothermia group (Fig. 1). The 
average pre-treatment infarct volumes in the normother-
mia and mild hypothermia groups were 25.03 ± 10.12 and 
24.91  ±  9.35  mm3, respectively. The average infarct vol-
ume in the mild hypothermia group was 13.45 ± 6.01 mm3 
24 h after the operation and 12.25 ± 7.42 mm3 7 days after 
the operation. The average infarct volume in the mild 
hypothermia group was significantly smaller than that in 
the normothermia group at both 24 h and 7 days after the 
operation (p < 0.05; Table 1).
Neurological scores after intra‑arterial mild hypothermia
The neurological deficit scores were 16.75  ±  8.24 and 
16.25  ±  8.51 in the normothermia group and mild 
hypothermia group, respectively. The mean neuro-
logical deficit scores for the mild hypothermia group 
were 10.04  ±  6.85 at 24  h, 9.06  ±  6.20 at 7  days, and 
7.06  ±  5.13 at 1 mo. The neurological scores in the 
mild hypothermia group prominently improved at 24 h, 
7 days, and 1 mo after the operation compared with those 
scores in the normothermia group (p < 0.05; Table 2).
Clinical characteristics of the patients after both 
treatments
The blood pressure, heart rate, blood glucose, blood 
gas, and coagulation conditions of the patients in the 
two groups were recorded at 24  h after the operation 
and compared. No significant changes in these clinical 
characteristics were observed between the two groups 
(p  >  0.05; Table  3). There was no significant differ-
ence regarding complications between the two groups. 
Included in this analysis were embolization into new ter-
ritories outside the target downstream territory of the 
occluded vessel in 2 of the 26 patients (7.7%) and proce-
dure-related vessel dissections in 1 patient (3.8%).
Discussion
Middle cerebral artery occlusion generally leads to a mas-
sive cerebral infarction, which has a poor prognosis that 
includes severe disability and death. Thus, timely recov-
ery of blood flow into the infarct area is critical for these 
patients. The recanalization rate for intravenous throm-
bolysis of a middle cerebral artery occlusion is low; thus, 
intra-arterial thrombolysis has been increasingly applied 
in clinical practice to greatly improve the recanalization 
rate. A retrospective study of 350 patients with acute 
stroke undergoing a variety of endovascular treatment 
techniques found that angioplasty combined with intra-
arterial thrombolysis can greatly improve the recanaliza-
tion rate (Brekenfeld et al. 2005). Among our 22 patients 
undergoing thrombolysis and angioplasty, 19 patients 
were completely recanalized and only 3 patients were 
partially recanalized. The high recanalization rate in our 
study is likely due to our intra-vascular technique and 
strict patient inclusion criteria.
Since the first use of mild hypothermia induction 
for clinical treatment by the American neurosurgeon 
Fay in 1938, clinical studies of mild hypothermia have 
been successively reported. Since the 1980s, several 
studies on the application of mild hypothermia for cer-
ebral ischemia have been carried out (Baker et al. 1991; 
Ridenour et al. 1992; Zausinger et al. 2000). These stud-
ies have shown that the induction of mild hypother-
mia between 28 and 33  °C has neuroprotective effects. 
In the clinic, ice blankets, ice caps, and alcohol sponge 
baths are often used to reduce body temperature. At the 
International Stroke Conference in 2010, a preliminary 
report of a clinical trial using endovascular hypothermia 
combined with intravenous thrombolysis for the treat-
ment of acute ischemic stroke showed that mild hypo-
thermia treatment is safe and feasible (Hemmen et  al. 
2010). Another study used mild hypothermia combined 
with interventional arterial thrombolysis for the treat-
ment of acute ischemic stroke and achieved the desired 
cerebral protective effects (Ding et  al. 2002). Subse-
quently, numerous studies have confirmed that mild 
hypothermia after stroke can protect brain structure 
and function at the cellular level (De Georgia et al. 2004; 
Hemmen and Lyden 2007; Krieger et al. 2001; Zausinger 
et al. 2003; Zhang et al. 2009). One meta-analysis of 101 
animal experiments showed that mild hypothermia can 
simultaneously reduce infarct volume by 44% on aver-
age and increase neurobehavioral scores by 46% (van 
der Worp et  al. 2007). Subsequent experiments dem-
onstrated that localized mild hypothermia combined 
with intra-arteriovenous thrombolysis is highly effective 
(Chen et al. 2013; Choi et al. 2010; Guluma et al. 2006; 
Hong et  al. 2014; Konstas et  al. 2007; Piironen et  al. 
2014; Zhao et al. 2009). Here, we found that the average 
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Fig. 1 The representative MRIs were presented in the normothermia group and mild hypothermia group. a The representative MRI of preoperative 
in the normothermia group. b The representative MRI of postoperation 1 week in the normothermia group. c The representative MRI of preopera-
tive in the mild hypothermia group. d The representative MRI of postoperation 1 week in the mild hypothermia group
Table 1 The infarct volumes (mm3) in the two groups at different time points (mean ± SD)
* P < 0.05 versus the normothermia group
Groups The infarct volumes  
in pre‑treatment
The infarct volumes  
after the operation time
0 h 24 h 7 days
Normothermia 25.03 ± 10.12 25.56 ± 10.22 26.26 ± 10.86
Mild hypothermia 24.91 ± 9.35 13.45 ± 6.01* 12.25 ± 7.42*
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infarct volume decreased from 25 to 13 cm3 in the first 
24 h for the hypothermia group, which was nearly a 50% 
volume reduction. Several experimental studies have 
confirmed that the therapeutic effects of mild hypother-
mia occur through blocking of reperfusion injury. In the 
early stage of a cerebral infarction, mild hypothermia 
therapy can reduce brain tissue injury in the ischemic 
penumbra and improve cerebrovascular autoregula-
tion, thereby reducing neuronal cell death. In addition, 
mild hypothermia can protect the blood–brain barrier, 
reduce cerebral edema, and decrease the influx of cal-
cium to block its neurotoxic effects (Krieger and Yenari 
2004; Rogalewski et al. 2006). In addition to the signifi-
cant infarct volume reduction, average NIHSS scores at 
various time points were roughly 2 points lower in the 
hypothermia group. There was a statistically significant 
difference between the 2 groups. The clinical symp-
toms improved have three time points, and infarct vol-
ume has three time points. The average NIHSS scores 
for the hypothermia group at 24 h and 7 days after sur-
gery were lower than the average pre-operation score. 
Although the NIHSS scores were very close at 7 days 
post-operation, we confirmed that the scores were true 
and accurately measured. The present study used a small 
sample size; therefore, the results could not be further 
analyzed by stratification of the ischemia and reperfu-
sion duration after mild hypothermia and thromboly-
sis treatment. Thus, future studies should continue to 
investigate the therapeutic efficacy of mild hypothermia 
combined with intra-arteriovenous thrombolysis after 
cerebral infarction.
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